Drug Profile


Alternative Names: Alphadolone; Alphadolone acetate; R 140; V-140

Latest Information Update: 28 Sep 2005

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Monash University
  • Class Analgesics; General anaesthetics; Pregnanes
  • Mechanism of Action GABA A receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Cancer pain

Most Recent Events

  • 22 Sep 2005 Discontinued - Phase-I for Cancer pain in World (PO)
  • 03 Oct 2003 RiboTargets has been integrated into British Biotech, which has merged with Vernalis Group to form Vernalis
  • 23 Sep 2003 Phase-I clinical trials in Cancer pain in World (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top